Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Starpharma starts Phase 2 VivaGel trial
The trial expects to evaluate women with a prior history of recurrent BV, and the product will be used every second day. The company will recruit around 200
The trial expects to evaluate women with a prior history of recurrent BV, and the product will be used every second day. The company will recruit around 200
The collaboration allows to bring MJFF’s Parkinson’s Progression Markers Initiative (PPMI) clinical study to Australia. The Shake It Up Foundation will raise funds for PPMI and other Parkinson’s
Sinovac’s net income was $1.88m, compared to $1.56m for the same period in the prior year. The company’s operating income was $3.13m for the second quarter ended 30
Following the signing of the expended deal, SOBI has placed an additional order for vials of Ruconest from Pharming. The shipment forms part of SOBI’s preparation for the
The licensing deal allows Roche to get milestone payments from Chugai Pharma. Chugai Pharma intends to begin a Phase I clinical trial for BRAF mutation-positive metastatic melanoma in
Prior to Addex, Chowrira worked as the senior vice president & chief operating officer of Nektar Therapeutics till January 2011. Before Nektar, Chowrira worked as the executive director
Simvastatin is used together with diet and exercise to reduce the amount of ‘bad cholesterol’ (low-density lipoprotein cholesterol or LDL-C) in the blood. The US Food and Drug
Colcrys is a single-ingredient colchicine product, indicated for the prophylaxis and treatment of gout flares, and for the treatment of Familial Mediterranean Fever (FMF). The studies are intended
Currently, the company has started designing a Phase III trial program and protocol to evaluate AmiKet in patients with chemotherapy-induced neuropathic pain (CIPN) to submit the new drug
Nordion provides targeted therapies and sterilization technologies to pharma and biotechnology companies, hospitals, clinics and research laboratories. Nordion will initially implement Pilgrim’s automated Document Management and Change Management